Dear members of the SB,
As part of the strategy to resolve the worldwide shortage of thrombolytic therapy, the BSC has been informed that Boehringer-Ingelheim will temporarily produce Actilyse vials with latex plugs that could also contain traces of Gentamycine. These vials could be encountered in your local hospital from the end of October onward (and will likely be produced for several months).
BI states that boxes containing vials with latex plugs and vials that could contain traces of Gentamycine will be clearly labeled by stickers (see photograph). These vials should never be administered to patients with a latex/rubber sensitivity or sensitivity to Gentamycine.
27/10/2023 – CVD awareness action
We need to implement health objectives into a Belgian Cardiovascular Health Plan. These objectives are critical to reduce mortality and morbidity caused by cardiovascular diseases. This plan was put forward by the newly formed Belgian Alliance for Cardiovascular Health (BACH). An awareness action at the Chamber of Representatives on November 9th was held to get political awareness and support.
Cardiovascular diseases are, together with cancer, the leading cause of death in Belgium. Yet they remain inadequately addressed. Over 1,000,000 people in Belgium suffer from these silent killers, resulting in 30,000 deaths and 4.5 billion euros in annual healthcare costs, with projections of further increases.
As being part of BACH, the first multi-stakeholder collaboration of universities, prevention organizations, scientific associations, and industry companies, we participated in the awareness action in the Chamber of Representatives in Brussels. We were glad to see many MP’s show their heart for the Belgian Cardiovascular Health Plan.
BACH is the multistakeholder alliance of: Hôpital Erasme – ULB, Belgian Stroke Council, Belgian Heart League, Saint-Luc UCLouvain, Belgian Society of Cardiology, UGent, Belgian Atherosclerosis Society, CHU UCL Namur, UZ Gent, Belgian Society of Cardiology, CHU de Liège, EAPC, Jessa ziekenhuis, AZ Groeninge, Belgian Heart League, UZ Leuven, AZ Sint-Jan, Belgian Hypertension Committee, Amgen, AstraZeneca, Bayer, Bristol Myers Squibb, MSD Belgium, Novartis, Novo Nordisk, Sanofi Belgium and Servier.
#cardiovasculardiseases #Heartplan #CVD